Early Pregnancy Flashcards
Definition of a miscarriage
TVS: MSD > 20mm w no FP
FP > 7mm w no FH
TAS: MSD >25mm w no FP
FP >8mm w no FH
Difference between complete and incomplete miscarriage
ETT <15 = complete, >15mm =incomplete
PUV vs PUL
PUV: MGSD </=20mm, no FP OR FP <7mm w no FH
PUL no IUGS seen OR IUGSw no YS
Management of miscarriage
Conservative - rpt USS 2/52
Medical: 80=91% effective. Mife 200mcg+ miso 800mcgx 2, rpt USS 2/52. ADRS: N&V, diarrhoea, PVB. Admit if MGSD >50mm
Surgical: ERPC, PT 2/52 later, Anti-D
Risk factors for recurrent miscarriage
Maternal age
Smoking
Caffeine
ETOH
Causes of recurrent miscarriage
ChAII TEA
Chromosomal - parental rearrangements + embryonic abnormalities
Antiphospholipidsyndrome
Immune
Infective
Thrombophilia
Endocrine
Anatomical
Role & effect of antiphospholipid syndrome
Includes lupus anticoagulant, antiB2 gylcoprotein ab, anticardiolipin abb
Adverse outcomes: early pregnancy loss, MTL, PTB
Inhibits trophoblastic function and differentiation. Activates complement pathways at mat/fet interface –> inflammatory response; thrombosis of uteroplacental vasculature in later pregnancy
Effects reversed with LMWH
Diagnosis of ectopic pregnancy
Serial HCG measurement
TAS/ TVS:
No IUGS + YS
60% homogenous adnexal mass adjacent to ovary
20% hypoechoic ring/ bagel sign
13% GS+FP
Types of ectopics
Tubal - bagel sign/ homogenous adnexal mass
Cervical - empty uterus, barrel-shaped cervix, GS below level of internal os, absence of sliding sign
Scar - GS low in uterine cavity. MRI 2nd line
Interstitial - empty uterine cavity, POC/GS in intramural part of tube + surrounded by <5mm myometrium
Cornual - visualisation of single interstitial portion of fallopian tube in main uterine body, GS/ POC seen mobile and separate fro uterus + completely surrounded by myometrium + vascular pedicle adjoining GS to unicornuate uterus
MTX candidate
- haemodynamically stable
- low HCG, ideally <1500 (NICE 1500-5000)
- No FH
- certainty of no viable IUP
- willingness to attend for F/U
- no known sensitivity to MTX
NICE: - no significant pain
- unruptured, w mass <35mm and no visible FH
R/F for ectopic pregnancy
- infertility (x2)
- tubal pathology (x3)
- documented salpingitis (x4)
- prev TL ( 1/3)
- pregnancy w IUCD (1/2)
- prev ectopic( 1 prev - >10%, 2 prev >25%)
MTX MOA & mx plan
MOA : Folic acid antagonist –> inhibits RNA & DNA synthesis by deactivating dihydrofolate reductase
Dose : 1mg/kg
HCG D0, D4 & D7
Monitor LFTs (hepatotoxic)
If decrease <15%, rpt MTX dose
USS appearance molar pregnancy
Complete: snowstorm appearance, no embryo, bilateral thecal cystrs
Partial: embryo, cystic spaces in placenta
Pre-op management molar pregnancy
Ix: FBC, LFTs, U&E, CXR
F/U post molar pregnancy
Evacuation (12mm catheter) + anti-D if required
Monitor serum hcg weekly until normalised x 3/52
Normalisation <8/52 —> monitor for 6/12post ERPC
Normalisation > 8/52 –> monitor for 6/12 post normalisation